PharVision Advisers »

Curtiss-Wright shares owned by PharVision Advisers

Quarter-by-quarter ownership of Curtiss-Wright (CW) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Curtiss-Wright

Tip: Access up to 7 years of quarterly data

All positions including Curtiss-Wright held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Curtiss-Wright by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-03-31 $390k 1.2k 317.27

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Curtiss-Wright

BlackRock
Vanguard Group
State Street Corporation
Invesco
Geode Capital Management
TD Asset Management
Van Eck Associates Corp.
Massachusetts Financial Services
PRIMECAP Management Company
AQR Capital Management
Bank of New York Mellon
American Century Companies
Charles Schwab Investment Management
Northern Trust
William Blair Investment Management

View all funds holding Curtiss-Wright